BRIEF published on 09/26/2025 at 14:50, 4 months 9 days ago EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
PRESS RELEASE published on 09/26/2025 at 14:45, 4 months 9 days ago enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRIEF published on 09/15/2025 at 14:50, 4 months 20 days ago EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRIEF published on 09/15/2025 at 14:50, 4 months 20 days ago EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
PRESS RELEASE published on 09/15/2025 at 14:45, 4 months 20 days ago enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRIEF published on 08/20/2025 at 13:05, 5 months 16 days ago EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRIEF published on 08/20/2025 at 13:05, 5 months 16 days ago EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
PRESS RELEASE published on 08/20/2025 at 13:00, 5 months 16 days ago enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRIEF published on 08/15/2025 at 15:26, 5 months 21 days ago EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRIEF published on 08/15/2025 at 15:26, 5 months 21 days ago EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Published on 02/06/2026 at 03:50, 2 hours 35 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 3 hours 40 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 5 hours 28 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 6 hours 25 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 7 hours 10 minutes ago Amarc Further Expands Its Toodoggone Technical Team
Published on 02/06/2026 at 06:05, 19 minutes ago Driven by Chairman Junhyuk Bang's Visionary Leadership, Coway Announces Financial Results for Q4 and FY2025
Published on 02/06/2026 at 05:50, 34 minutes ago CGTN: Xi Jinping's same-day calls with Putin and Trump underscore China's role in global stability
Published on 02/05/2026 at 19:27, 10 hours 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 11 hours 38 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 12 hours 15 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 19:15, 11 hours 10 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 11 hours 10 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 11 hours 10 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
